Xylem Reports First Quarter 2021 Results

Revenue growth 12% on a reported basis, 8% organically Double-digit orders growth across all business segments, reflecting strong commercial momentum and underlying demand in critical infrastructure Adjusted EBITDA margin of 17.1%, up 480 basis points; net income as a percentage of revenue was 6.9%, up 350 basis points Reported net income of $87 million or... Read more

Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that it has filed an action in the General Court of the European Union asking for annulment of the European Commission’s decision asserting jurisdiction to review Illumina’s acquisition of GRAIL. The Commission asserted jurisdiction to review the acquisition under Article 22 of the EU Merger Regulation on... Read more

Thermo Fisher Scientific Reports First Quarter 2021 Results

WALTHAM, Mass., April 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021. First Quarter 2021 Highlights First quarter revenue increased 59% to $9.91 billion. First quarter GAAP diluted earnings per share (EPS) increased 198% to $5.88.... Read more

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

About 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly) Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a... Read more

Danaher Reports First Quarter 2021 Results

WASHINGTON, April 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended April 2, 2021, net earnings were $1.7 billion, or $2.29 per diluted common share which represents a 182.5% year-over-year... Read more

Salt Crystallization in Carbon Dioxide Storage Reservoirs

Reservoir rocks are of particular interest to geoscientists as they can act as a reservoir for carbon dioxide storage. Carbon capture and storage (CCS) is a process whereby carbon emissions are captured from sources like coal-fired power plants and stored in geological reservoirs so they will not enter the atmosphere. What is your goal for... Read more

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization – Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry – Adds highly complementary services for the company’s fastest growing end market – Offers both meaningful cost and revenue synergies which will further accelerate growth... Read more

PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021

 Company also announces appointment of Steve Willoughby as vice president, investor relations WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 13, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of 98% and 90%, respectively, for the first quarter ended April 4, 2021. PerkinElmer’s... Read more

Bruker Announces First Quarter 2021 Preliminary Revenue

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 – $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates... Read more